AI-designed drugs set to enter clinical trials: A new era of health or a Trojan horse for corporate control?

Estimated read time 1 min read

(NaturalNews) Google DeepMind CEO Demis Hassabis announced that AI-designed drugs from Isomorphic Labs, a Google spin-out, are expected to enter clinical…

You May Also Like

More From Author